1. Home
  2. KEQU vs ANVS Comparison

KEQU vs ANVS Comparison

Compare KEQU & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$41.00

Market Cap

106.6M

Sector

Industrials

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$2.69

Market Cap

111.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
ANVS
Founded
1906
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
111.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
KEQU
ANVS
Price
$41.00
$2.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
2.4K
354.2K
Earning Date
03-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.92
EPS
1.86
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.16
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$1.11
52 Week High
$60.89
$5.50

Technical Indicators

Market Signals
Indicator
KEQU
ANVS
Relative Strength Index (RSI) 52.89 48.70
Support Level $36.71 $2.27
Resistance Level $41.38 $2.97
Average True Range (ATR) 0.94 0.20
MACD 0.09 0.07
Stochastic Oscillator 38.95 55.50

Price Performance

Historical Comparison
KEQU
ANVS

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: